Duke University School of Medicine

What Duke University School of Medicine does

Duke University School of Medicine is a private academic medical institution founded in 1930 and operating under the auspices of Duke University and Duke University Health System in Durham, North Carolina. The institution fulfills four core missions: medical and graduate education, biomedical research, patient care, and community partnership. It operates a multi-hospital health system (Duke University Hospital, Duke Regional Hospital, Duke Raleigh Hospital) alongside extensive outpatient clinics, and runs MD, PhD, health professions, and continuing medical education programs that draw students nationally and internationally.

Research operations span basic science, clinical and translational research, and an emerging AI-in-health pillar. The institution has developed proprietary research platforms and assets including the Precision Genomics Collaboratory (an integrated genomics research community), the Duke COVID-19 Shared Data and Specimen Repository (20,000+ specimens from 4,400+ individuals), the DunedinPACE epigenetic clock for measuring biological age, and first-in-class beta-arrestin controlling molecules published in Nature. It collaborates on AI-driven platforms such as Evaxion's AI-Immunology platform for glioblastoma vaccine design and co-leads an AI maturity framework for healthcare with Vanderbilt University Medical Center.

Revenue is generated through three streams: patient care services billed through Duke Health system hospitals and clinics, tuition and fees from educational programs, and research grants from federal agencies (NIH, NSF), private foundations (Gordon and Betty Moore Foundation, The Duke Endowment), and industry sponsors. The Duke Endowment's $100 million investment in Duke Science and Technology has funded aggressive faculty recruitment, with 15+ DST Scholars and multiple high-profile hires across neurobiology, immunology, cell biology, and molecular genetics. The institution is led by Dean Mary E. Klotman, MD, and benefits from two Nobel laureates on faculty: Robert J. Lefkowitz (2012 Chemistry) and Paul Modrich (2015 Chemistry).

Name

Duke University School of Medicine

Legal name

Duke University School of Medicine

Website

https://medschool.duke.edu

Company type

Private

Founded year

1930

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Duke University School of Medicine is a private academic medical institution founded in 1930 in Durham, NC, operating medical education, biomedical research, and patient care through Duke Health system hospitals and clinics.

Ownership category

akta.pro rank

Product category

Academic Medical Center

NAICS

Colleges, Universities, and Professional Schools (6113), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical Laboratories (621511)

SIC

Services-Educational Services (8200), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Medical Schools (MD/DO Granting) (EDAHAGAB)

akta.pro secondary industries

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI), Comprehensive Doctoral Research Universities (Multi-Disciplinary) (EDAHABAA), Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC)

Keywords

• Medical education programs
• Biomedical research services
• Clinical patient care
• Translational research services
• Healthcare professional training

Headquarters

HQ city

Durham

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

1. Patient Care Services: Clinical care provided through Duke University Hospital, Duke Regional Hospital, Duke Raleigh Hospital, and numerous outpatient clinics. Revenue generated from medical services billed to patients and insurance.
2. Educational Programs: Medical education (MD programs), biomedical graduate education (PhD programs), health professions education, graduate certificates, and continuing medical education generate tuition revenue and training fees.
3. Research Grants and Sponsored Programs: Federal and private research funding from NIH, NSF, foundations, and industry sponsors. Examples include $1.25M Gordon and Betty Moore Foundation grant for AI maturity framework and $100M Duke Science and Technology initiative from The Duke Endowment.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Duke University School of Medicine operates as an academic medical center delivering medical education (MD, Biomedical PhD, Graduate Medical Education, Continuing Medical Education), biomedical and clinical research across basic science, translational, and artificial intelligence domains, and clinical patient care through the Duke Health system (Duke University Hospital, Duke Regional Hospital, Duke Raleigh Hospital, and outpatient clinics). The school runs dedicated research centers including the Precision Genomics Collaboratory, Duke Science and Technology initiative, and specialized cell therapy programs.

Product overview

Duke University School of Medicine is an academic medical center offering a portfolio of educational programs, research initiatives, and healthcare services. The institution operates as a unified academic health system with undergraduate research programs (Summer Undergraduate Research Opportunities), specialized research centers (Precision Genomics Collaboratory, Duke Science and Technology Initiative), data repositories (COVID-19 Shared Data and Specimen Repository), and clinical cell therapy programs. The school is organized around four mission pillars: Education, Research, Patient Care, and Community Partnership, supported by interdisciplinary research initiatives spanning genomics, AI in health, climate and health, and regenerative medicine.

Differentiator

Problem solved

Functional benefit

Brands

• Precision Genomics Collaboratory: A multidisciplinary research unit bringing together all Duke units focused on genomics research.
• Duke COVID-19 Shared Data and Specimen Repository (CSDSR)
• Duke Science and Technology
• Duke Center for Health Informatics
• Climate and Health Research Initiative

Products and services

• Doctor of Medicine (MD) Program
• Biomedical PhD Programs
• Summer Undergraduate Research Opportunities (SURP)
• Graduate Medical Education (Residency and Fellowship)
• Continuing Medical Education
• Clinical Patient Care Services (Duke Health)
• Stem Cell Research and Cell Therapy Programs

Quantifiable outcome

• 98% positive outcomes in nature-based intervention studies for psychiatric patients
• +2 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

Partnerships

Three partnerships are on record, tiered major and core.

• Yale School of Medicine and Yale New Haven HospitalmajorStrategic or Co-development Partner · 21 May 2026Collaborative peer-reviewed study led by Truveta in collaboration with Yale and Duke, published in JAMA Network Open, studying follow-up care for over 340,000 heart failure patients. Duke University School of Medicine contributed as a research partner.
• Evaxion A/ScoreStrategic or Co-development Partner · 17 April 2026Collaboration on AI-Immunology platform for glioblastoma vaccine design. Duke researchers worked with Evaxion to identify endogenous retrovirus-derived antigens as vaccine targets. The findings were presented at the AACR Annual Meeting in San Diego on April 22, 2026.
• Vanderbilt University Medical Center (VUMC)coreStrategic or Co-development Partner · 9 November 2023VUMC and Duke University School of Medicine received a $1.25 million grant from the Gordon and Betty Moore Foundation to develop a framework for measuring AI maturity in healthcare organizations. The project aims to ensure health systems are prepared for trustworthy AI deployment.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Vanderbilt University School of Medicine: Active Duke partner on the AI Maturity Framework with VUMC; comparable private research medical school with strengths in biomedical informatics, genomics, and clinical and translational science.
• Harvard Medical School: Top-tier private medical school with analogous MD/PhD programs, NIH-funded research portfolio, and integrated teaching hospital (Mass General Brigham). Direct competitor for faculty recruitment, federal funding, and industry partnerships.
• Johns Hopkins University School of Medicine: Closest peer in size, mission, and structure: private research medical school with Nobel-caliber faculty, large NIH-funded research base, and integrated academic health system. Competes directly for physician-scientist talent and federal grants.
• Stanford University School of Medicine: Private research medical school with strengths in genomics, AI in health, and biomedical innovation. Direct competitor for faculty in AI/biotech convergence and tech transfer outcomes.
• University of Pennsylvania Perelman School of Medicine: Ivy League private medical school with comparable NIH funding scale, gene therapy leadership, and integrated health system. Comparable in structure and competition for biomedical talent.
• Washington University School of Medicine in St. Louis: Private research medical school with elite NIH-funded basic science departments and integrated Barnes-Jewish Hospital system. Direct competitor for physician-scientist recruitment and research funding.
• Yale School of Medicine: Private research medical school with comparable research output and integrated Yale New Haven Health. Already an active research collaborator with Duke (heart failure JAMA study), and direct competitor for federal funding.
• Columbia University Vagelos College of Physicians and Surgeons: Ivy League private medical school with analogous basic science and clinical research portfolio and integrated NewYork-Presbyterian hospital system. Competes for faculty and federal funding.
• UCSF School of Medicine: Top research medical school with leading NIH funding, biotech ecosystem adjacency (SF Bay Area), and excellence in precision medicine, genomics, and aging research — all areas of Duke strategic focus.
• Weill Cornell Medicine: Private medical school with comparable NIH research funding scale, integrated NewYork-Presbyterian clinical enterprise, and strong industry partnership profile. Direct competitor for biomedical faculty and translational research leadership.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/dukemedschool
• YouTubeyoutube.com/user/DukeMedSchool
• Facebookfacebook.com/DukeSchoolofMedicine
• LinkedInlinkedin.com/company/duke-university
• Instagraminstagram.com/dukeschoolofmedicine

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries8 records

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Duke University School of Medicine